Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,888
Closed -$35.3K 328
2024
Q4
$35.3K Sell
12,888
-10,000
-44% -$37K ﹤0.01% 374
2024
Q3
$125K Sell
22,888
-52,301
-70% -$391K ﹤0.01% 404
2024
Q2
$1.26M Buy
+75,189
New +$908K 0.04% 265
2024
Q1
Sell
-81,420
Closed -$1.35M 515
2023
Q4
$1.35M Buy
81,420
+9,216
+13% +$153K 0.04% 234
2023
Q3
$1.63M Buy
72,204
+1,500
+2% +$42.5K 0.03% 268
2023
Q2
$2.26M Buy
70,704
+6,334
+10% +$203K 0.05% 271
2023
Q1
$1.92M Buy
+64,370
New +$2.72M 0.05% 322
2022
Q4
Sell
-39,639
Closed -$1.59M 26
2022
Q3
$1.59M Buy
39,639
+4,081
+11% +$208K 0.02% 679
2022
Q2
$1.35M Buy
+35,558
New +$1.29M 0.01% 725

Other funds holding AGEN

UBS O'Connor's AGEN Position: Q1 2025 in Review

UBS O'Connor sold out of Agenus (AGEN) in Q1 2025, closing a stake of 12,888 shares — an estimated $35.3K sold.

UBS O'Connor first reported a position in AGEN in Q2 2022 and held it in 9 quarters. The position peaked at $2.26M in Q2 2023. 88 funds tracked by Wall St. Rank hold AGEN as of Q1 2025.

  • UBS O'Connor reported no remaining Agenus position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 12,888 Agenus shares in Q1 2025, an estimated $35.3K.
  • UBS O'Connor first reported a position in Agenus in Q2 2022 and held it in 9 quarters.
  • UBS O'Connor's Agenus position peaked at $2.26M in Q2 2023.
  • 88 funds tracked by Wall St. Rank held Agenus as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.